Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China
· Delayed Price · Currency is CNY 37.89
-0.99 (-2.55%)
At close: Apr 29, 2026
SHE:301281 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 23.54 | 16.55 | 60.45 | 77.04 | 91.28 | 78.17 | Upgrade
|
| Depreciation & Amortization | 47.67 | 47.67 | 46.86 | 48.95 | 33.63 | 26.86 | Upgrade
|
| Other Amortization | 4.61 | 4.61 | 0.38 | 1.64 | 1.69 | 1.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.3 | -0.3 | -0.08 | -0.35 | -0.37 | 0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.36 | 1.36 | 0.92 | 0.3 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.76 | -4.76 | -12.94 | -12.74 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 1.78 | 1.78 | 0.29 | 0.31 | 0.84 | 0.11 | Upgrade
|
| Other Operating Activities | 39.82 | 15.13 | 7.92 | 2.66 | 2.43 | 0.09 | Upgrade
|
| Change in Accounts Receivable | -31.87 | -31.87 | -162.93 | -18.88 | -43.02 | -42.78 | Upgrade
|
| Change in Inventory | -34.26 | -34.26 | -28.47 | -42.79 | 16.07 | -16.2 | Upgrade
|
| Change in Accounts Payable | 28.26 | 28.26 | 26.68 | -20.28 | 6.28 | -5.76 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 8.88 | Upgrade
|
| Operating Cash Flow | 75.14 | 43.47 | -60.52 | 37.03 | 115.86 | 52.02 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -68.04% | 122.71% | -50.53% | Upgrade
|
| Capital Expenditures | -128.29 | -137.05 | -296.38 | -70.15 | -31.11 | -20.19 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.5 | 0.5 | 0.1 | 0.2 | 0.4 | 0.29 | Upgrade
|
| Cash Acquisitions | - | - | -1.66 | - | - | - | Upgrade
|
| Investment in Securities | 258.92 | 253.39 | 105.22 | -538.47 | - | - | Upgrade
|
| Other Investing Activities | -1.25 | 4.58 | 5.15 | 6.3 | - | - | Upgrade
|
| Investing Cash Flow | 129.88 | 121.42 | -187.58 | -602.13 | -30.71 | -19.9 | Upgrade
|
| Long-Term Debt Issued | - | 70.16 | 45.62 | - | - | - | Upgrade
|
| Total Debt Issued | 93.55 | 70.16 | 45.62 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -3.56 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -3.6 | -3.56 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 89.96 | 66.6 | 45.62 | - | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 782.94 | - | - | Upgrade
|
| Common Dividends Paid | -25.98 | -24.82 | -32.56 | -30.94 | - | - | Upgrade
|
| Dividends Paid | -25.98 | -24.82 | -32.56 | -30.94 | - | - | Upgrade
|
| Other Financing Activities | 5.56 | - | 2.01 | -12.2 | -1.81 | -3.87 | Upgrade
|
| Financing Cash Flow | 69.54 | 41.78 | 15.07 | 739.81 | -1.81 | -3.87 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.17 | 0.45 | 0.59 | 0.52 | 0.28 | -0.11 | Upgrade
|
| Net Cash Flow | 274.39 | 207.12 | -232.44 | 175.23 | 83.63 | 28.13 | Upgrade
|
| Free Cash Flow | -53.15 | -93.58 | -356.9 | -33.12 | 84.75 | 31.83 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 166.28% | -67.53% | Upgrade
|
| Free Cash Flow Margin | -11.86% | -23.50% | -76.96% | -7.40% | 19.14% | 7.56% | Upgrade
|
| Free Cash Flow Per Share | -0.48 | -0.85 | -3.31 | -0.33 | 1.04 | 0.39 | Upgrade
|
| Cash Income Tax Paid | 15.37 | 14.21 | 19.13 | 25.19 | 24.79 | 27.67 | Upgrade
|
| Levered Free Cash Flow | -38 | -52.4 | -280.59 | -39.21 | 60.98 | 81.63 | Upgrade
|
| Unlevered Free Cash Flow | -37.99 | -52.39 | -280.57 | -39.21 | 60.98 | 81.63 | Upgrade
|
| Change in Working Capital | -38.56 | -38.56 | -164.33 | -80.77 | -13.65 | -54.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.